04/08/2024 7:03 AM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/25/2024 4:00 PM | Bhatt Padmanabh P. (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 4:00 PM | Bhatt Padmanabh P. (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/21/2024 4:01 PM | Bhatt Padmanabh P. (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 5:39 PM | Bhatt Padmanabh P. (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/14/2024 4:00 PM | Bhatt Padmanabh P. (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 3:23 PM | Bhatt Padmanabh P. (Reporting) Supernus Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
02/29/2024 4:00 PM | Khattar Jack A. (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 4:01 PM | Mottola Frank (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/22/2024 4:28 PM | Khattar Jack A. (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 1:33 PM | ARMISTICE CAPITAL, LLC (Filed by) Supernus Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/14/2024 6:06 AM | MACQUARIE GROUP LTD (Filed by) Supernus Pharmaceuticals (Subject)
| Form SC 13G | |
02/05/2024 8:21 AM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/19/2024 1:40 PM | BlackRock Inc. (Filed by) Supernus Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/10/2024 3:08 PM | Martin Tami Tillotson (Reporting) Supernus Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/26/2023 4:00 PM | Khattar Jack A. (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/26/2023 4:01 PM | Rubin Jonathan (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/16/2023 4:00 PM | Mottola Frank (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/16/2023 3:31 PM | NEWHALL CHARLES W III (Reporting) Supernus Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2023 3:14 PM | Supernus Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/02/2023 3:24 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/25/2023 3:19 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/18/2023 7:15 AM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/13/2023 4:00 PM | DEC TIMOTHY C (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/10/2023 3:31 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/06/2023 4:02 PM | DEC TIMOTHY C (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/07/2023 4:00 PM | Khattar Jack A. (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/07/2023 4:00 PM | Bhatt Padmanabh P. (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/01/2023 4:00 PM | Martin Tami Tillotson (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/30/2023 3:34 PM | Martin Tami Tillotson (Reporting) Supernus Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/29/2023 4:00 PM | Martin Tami Tillotson (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/25/2023 3:31 PM | Martin Tami Tillotson (Reporting) Supernus Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/21/2023 4:10 PM | Sensenig Bethany (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/21/2023 8:05 AM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/24/2023 3:08 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/20/2023 6:06 AM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |